Cue Biopharm announced that Lucinda Warren, who has served as Cue Biopharma’s (CUE) chief business officer, CBO, since September 2024, has been appointed chief financial and business officer, CFBO, effective February 9, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: